Evaluating Oregon's occupational public health surveillance system based on the CDC updated guidelines.


Journal

American journal of industrial medicine
ISSN: 1097-0274
Titre abrégé: Am J Ind Med
Pays: United States
ID NLM: 8101110

Informations de publication

Date de publication:
08 2020
Historique:
received: 01 02 2020
revised: 06 04 2020
accepted: 14 05 2020
pubmed: 3 6 2020
medline: 7 7 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

The Oregon Occupational Public Health Program (OOPHP) monitors occupational health indicators (OHIs) to inform occupational safety and health (OSH) surveillance. In 2018, OOPHP evaluated the performance of the OSH surveillance system and identified areas for future improvement. Following the Centers for Disease Control and Prevention (CDC) updated guidelines for evaluating public health surveillance systems, the OOPHP evaluation team engaged internal and external stakeholders using a mixed-methods approach. Operational measures for ten surveillance attributes were developed. Multiple data collection methods resulted in credible evidence for evaluation conclusions. Analyses included summary statistics and qualitative analysis of interviews, a focus group, and online surveys. Twenty stakeholders took part in this evaluation, with an average participation rate of 55%. Results showed the Oregon OSH surveillance system was simple, flexible, and highly accepted by its stakeholders. Funding security presents challenges for stability. A lack of timeliness of OHIs, low relevance of OHIs to local OSH issues, and the system's ineffectual data dissemination all limit the usefulness of the OSH surveillance system. A review of key data sources for the system showed good data quality and predictive value positive, but relatively poor sensitivity and representativeness. The evaluation team successfully adapted attributes and examples in the CDC guidelines to this Oregon OSH surveillance evaluation. The evaluation findings have informed the development of recommendations for improvements to OOPHP's OSH surveillance. Future research is needed to develop guidance specific to OSH surveillance evaluation.

Sections du résumé

BACKGROUND
The Oregon Occupational Public Health Program (OOPHP) monitors occupational health indicators (OHIs) to inform occupational safety and health (OSH) surveillance. In 2018, OOPHP evaluated the performance of the OSH surveillance system and identified areas for future improvement.
METHODS
Following the Centers for Disease Control and Prevention (CDC) updated guidelines for evaluating public health surveillance systems, the OOPHP evaluation team engaged internal and external stakeholders using a mixed-methods approach. Operational measures for ten surveillance attributes were developed. Multiple data collection methods resulted in credible evidence for evaluation conclusions. Analyses included summary statistics and qualitative analysis of interviews, a focus group, and online surveys.
RESULTS
Twenty stakeholders took part in this evaluation, with an average participation rate of 55%. Results showed the Oregon OSH surveillance system was simple, flexible, and highly accepted by its stakeholders. Funding security presents challenges for stability. A lack of timeliness of OHIs, low relevance of OHIs to local OSH issues, and the system's ineffectual data dissemination all limit the usefulness of the OSH surveillance system. A review of key data sources for the system showed good data quality and predictive value positive, but relatively poor sensitivity and representativeness.
CONCLUSIONS
The evaluation team successfully adapted attributes and examples in the CDC guidelines to this Oregon OSH surveillance evaluation. The evaluation findings have informed the development of recommendations for improvements to OOPHP's OSH surveillance. Future research is needed to develop guidance specific to OSH surveillance evaluation.

Identifiants

pubmed: 32483871
doi: 10.1002/ajim.23139
pmc: PMC7383881
doi:

Types de publication

Evaluation Study Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

713-725

Subventions

Organisme : NIOSH CDC HHS
ID : U60 OH008472
Pays : United States

Informations de copyright

© 2020 The Authors. American Journal of Industrial Medicine published by Wiley Periodicals LLC.

Références

J Occup Environ Med. 2000 Jan;42(1):25-34
pubmed: 10652685
Med Care. 2007 Oct;45(10 Supl 2):S96-102
pubmed: 17909391
BMC Public Health. 2011 Sep 29;11:744
pubmed: 21958054
MMWR Recomm Rep. 2001 Jul 27;50(RR-13):1-35; quiz CE1-7
pubmed: 18634202
J Agromedicine. 2020 Jan;25(1):86-95
pubmed: 31044658
Inj Prev. 2009 Apr;15(2):105-10
pubmed: 19346423
J Occup Environ Med. 2006 Sep;48(9):914-22
pubmed: 16966958
J Occup Environ Med. 2017 Apr;59(4):417-423
pubmed: 28628050
BMC Public Health. 2015 May 01;15:448
pubmed: 25928645
Health Serv Res. 2015 Aug;50 Suppl 1:1273-99
pubmed: 26150118
Public Health Rep. 2017 Jul/Aug;132(4):403-410
pubmed: 28609194
Am J Ind Med. 2017 Jul;60(7):599-620
pubmed: 28616885
Am J Ind Med. 2002 Dec;42(6):467-73
pubmed: 12439869
Am J Ind Med. 2020 Aug;63(8):713-725
pubmed: 32483871
Med Care Res Rev. 2007 Aug;64(4):449-68
pubmed: 17684112
Am J Ind Med. 2017 Jul;60(7):621-626
pubmed: 28543608
Public Health. 2015 May;129(5):561-8
pubmed: 25795017
Am J Ind Med. 2019 Jul;62(7):568-579
pubmed: 31104330

Auteurs

Liu Yang (L)

School of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, Oregon.

Crystal Weston (C)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Curtis Cude (C)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Laurel Kincl (L)

School of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, Oregon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH